Official EU label nameGlossary entry 29692

UROLITHIN A

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence

Markets checked

Markets with evidence

Evidence gaps

Resolved identifiers

Resolved substance identity

CAS:1143-70-0

Ingredient index records:

UROLITHIN A

Cosmetic functions: SKIN CONDITIONING - MISCELLANEOUS

Urolithin A is the organic compound that conforms to the formula:

Open full local profile Verify in official CosIng

1 matched or reported name

UROLITHIN A

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name UROLITHIN A.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Check the markets and their sources Search every market for this name

Chemical identity and properties

PubChem 2D chemical structure for CAS 1143-70-0

CAS 1143-70-0PubChem CID 5488186

Urolithin A

Urolithin A is a metabolite of ellagic acid. It has been demonstrated to stimulate mitophagy and improve muscle health in old animals and in preclinical models of aging. — DrugBank

IUPAC name: 3,8-dihydroxybenzo[c]chromen-6-one

Molecular formula: C13H8O4
Molecular weight: 228.20 g/mol
Exact mass: 228.04225873 Da
XLogP3: 2.3
Topological polar surface area: 66.8 Å²
Hydrogen-bond donors: 2
Hydrogen-bond acceptors: 4
Covalent units: 1
Defined stereocentres: 0

Also known as

3,8-dihydroxy-6H-benzo[c]chromen-6-one3,8-Dihydroxyurolithin6H-Dibenzo[b,d]pyran-6-one, 3,8-dihydroxy-3,8-Hydroxydibenzo-alpha-pyroneILJ8NEF6DTMitopure6H-Dibenzo(b,d)pyran-6-one, 3,8-dihydroxy-3,8-DIHYDROXYBENZO(C)CHROMEN-6-ONE

16 more reported names

3,8-dihydroxy-6H-benzo(c)chromen-6-oneRefChem:193319881-478-53,8-dihydroxy-6h-dibenzo[b,d]pyran-6-one3,8-Dihydroxy-6H-dibenzo(b,d)pyran-6-one3,8-dihydroxy-urolithinCHEBI:168442AC-31959urolithin-AUrolithin A?RIUPLDUFZCXCHM-UHFFFAOYSA-NUro-AUNII-ILJ8NEF6DTUrolithin A [WHO-DD]FT-0778244HMS6018O08

Open full PubChem record PubChem annotations 3D structure image

External database identifiers

ChEBI:CHEBI:168442
ChEMBL:CHEMBL1836264
EPA DTXSID:DTXSID40150694
PubMed:39725191
PubMed:35584623
PubMed:35330168
PubMed:34117375
PubMed:33671880
PubMed:32179165
PubMed:23811531
PubMed:23781257
PubMed:21972104
PubMed:21843938
PubMed:21294073
PubMed:20051378

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Additional authoritative substance research

Each link searches that source for this identity. A link is a research route, not a claim that the source holds an exact record. What each source is, and its legal weight

Cosmetic Ingredient Review safety assessments FDA Global Substance Registration System ILO/WHO International Chemical Safety Cards Japan NITE-CHRIP NIOSH Pocket Guide to Chemical Hazards OECD eChemPortal US EPA CompTox CTX APIs

Take this record further

Screen in a formula Open standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision